Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/INNOVENT-BIOLOGICS-INC-49476402/news/Innovent-Biologics-Announces-First-Patient-Dosed-in-A-Phase-1-Clinical-Trial-of-Anti-TIGIT-Monoclo-30669934/?utm_source=whatsapp&utm_medium=social&utm_campaign=share